journal article·2024-10

Matrix stiffening facilitates stemness of liver cancer stem cells by YAP activation and BMF inhibition

Di Ma, Qing Luo, Guanbin Song

Publisher page

Abstract

Matrix stiffening is one of the major risk factors for hepatocellular carcinoma (HCC) and drives tumor progression. The extracellular matrix (ECM) stiffness of HCC displays mechanical heterogeneity, with stiffness increasing from the core to the invasive frontier. The distribution of liver cancer stem cells (CSCs) is related to this mechanical property. However, it is not sufficiently understood how heterogeneous matrix stiffness regulates the stemness of CSCs. In this study, we developed an adjustable gelatin/alginate hydrogel to investigate the effect of various matrix stiffnesses on CSC stemness under three-dimensional culture conditions. Gelatin/alginate hydrogel with the stiffness of soft (5 kPa), medium (16 kPa), and stiff (81 kPa) were prepared by altering the concentration of calcium ions. It was found that a stiffer matrix promoted stemness-associated gene expression, reduced drug sensitivity, enhanced sphere-forming and clonogenic ability, and tumorigenic potential. Mechanistically, matrix stiffening facilitates CSC stemness by increasing Yes-associated protein (YAP) activity and inhibiting Bcl-2 modifying factor (BMF) expression. Knockdown of YAP or overexpression of BMF significantly attenuated matrix stiffening-induced stemness, suggesting the involvement of YAP and BMF in this process. Together, our results unravel the regulatory mechanism of heterogeneous matrix stiffness on CSC stemness and also provide a novel therapeutic strategy for eradicating CSCs and improving the efficiency of HCC treatment.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cellular Mechanics and Interactions · Hippo pathway signaling and YAP/TAZ · Microtubule and mitosis dynamics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (68)

Show source-provided references
1. Hepatocellular carcinoma: new developments10.1016/j.cld.2022.08.004 ↗
2. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries10.3322/caac.21660 ↗
3. Cirrhosis: a questioned risk factor for hepatocellular carcinoma10.1016/j.trecan.2020.08.005 ↗
4. The role of cancer-associated fibroblasts and fibrosis in liver cancer10.1146/annurev-pathol-052016-100322 ↗
5. Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells10.1002/hep.24108 ↗
6. Association between the degree of fibrosis in fibrotic focus and the unfavorable clinicopathological prognostic features of breast cancer10.7717/peerj.8067 ↗
7. Matrix stiffness mediates stemness characteristics via activating the Yes-associated protein in colorectal cancer cells10.1002/jcb.27532 ↗
8. Extracellular matrix and its therapeutic potential for cancer treatment10.1038/s41392-021-00544-0 ↗
9. Matrix rigidity controls epithelial-mesenchymal plasticity and tumor metastasis via a mechanoresponsive EPHA2/LYN complex10.1016/j.devcel.2020.05.031 ↗
10. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection10.1016/j.jhep.2018.10.022 ↗
11. N6-methyladenosine-mediated up-regulation of FZD10 regulates liver cancer stem cells’ properties and lenvatinib resistance through Wnt/β-catenin and Hippo signaling pathways10.1053/j.gastro.2023.01.041 ↗
12. The distribution of liver cancer stem cells correlates with the mechanical heterogeneity of liver cancer tissue10.1007/s00418-021-01979-w ↗
13. Inhibition of matrix stiffness relating integrin β1 signaling pathway inhibits tumor growth in vitro and in hepatocellular cancer xenografts10.1186/s12885-021-08982-3 ↗
14. Heterogeneous matrix stiffness regulates the cancer stem-like cell phenotype in hepatocellular carcinoma10.1186/s12967-022-03778-w ↗
15. Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis10.1007/s12072-010-9223-1 ↗
16. Aldehyde dehydrogenase 1A1 circumscribes high invasive glioma cells and predicts poor prognosis
17. Basic studies on radioimmunotargeting of CD133-positive HCT116 cancer stem cells10.2310/7290.2012.00008 ↗
18. Matrix stiffness potentiates stemness of liver cancer stem cells possibly via the Yes-associated protein signal10.1021/acsbiomaterials.1c00558 ↗
19. Fabrication of hydrogels with steep stiffness gradients for studying cell mechanical response10.1371/journal.pone.0046107 ↗
20. Conductive hydrogels based on industrial lignin: opportunities and challenges10.3390/polym14183739 ↗
21. Design properties of hydrogel tissue-engineering scaffolds10.1586/erd.11.27 ↗
22. Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment10.1098/rsif.2017.0137 ↗
23. Three-dimensional culture of mouse renal carcinoma cells in agarose macrobeads selects for a subpopulation of cells with cancer stem cell or cancer progenitor properties10.1158/0008-5472.CAN-10-2254 ↗
24. Stiffer matrix accelerates migration of hepatocellular carcinoma cells through enhanced aerobic glycolysis via the MAPK-YAP signaling10.3390/cancers12020490 ↗
25. Biophysical properties of hydrogels for mimicking tumor extracellular matrix10.1016/j.bioadv.2022.212782 ↗
26. Mechanical behaviour of alginate-gelatin hydrogels for 3D bioprinting10.1016/j.jmbbm.2017.12.018 ↗
27. Hydrogel microenvironments for cancer spheroid growth and drug screening10.1126/sciadv.aas8998 ↗
28. Effects of Yak skin gelatin on platelet activation10.1039/C8FO02513D ↗
29. Advanced mechanotherapy: biotensegrity for governing metastatic tumor cell fate via modulating the extracellular matrix10.1016/j.jconrel.2021.06.002 ↗
30. Epithelial-mesenchymal transition: a fundamental cellular and microenvironmental process in benign and malignant prostate pathologies10.3390/biomedicines12020418 ↗
31. Role of the mechanical microenvironment in cancer development and progression10.20892/j.issn.2095-3941.2019.0437 ↗
32. Role of YAP/TAZ in mechanotransduction10.1038/nature10137 ↗
33. Pin1/YAP pathway mediates matrix stiffness-induced epithelial-mesenchymal transition driving cervical cancer metastasis via a non-Hippo mechanism10.1002/btm2.10375 ↗
34. Geometric confinement guides the expression of cancer stem cell molecular markers CD44 via cell traction forces10.1021/acsbiomaterials.0c00366 ↗
35. MiR-221 regulates proliferation and apoptosis of ovarian cancer cells by targeting BMF
36. Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates gamma irradiation-induced thymic lymphoma development10.1084/jem.20071658 ↗
37. Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad10.1182/blood-2009-03-212670 ↗
38. Identification and cloning of EI24, a gene induced by p53 in etoposide-treated cells
39. Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway10.1016/j.ccell.2019.12.006 ↗
40. Biomechanical profile of cancer stem-like cells derived from MHCC97H cell lines10.1016/j.jbiomech.2015.11.007 ↗
41. Tumor matrix stiffness provides fertile soil for cancer stem cells10.1186/s12935-023-02992-w ↗
42. Versicanv1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway10.1038/s41388-019-1052-7 ↗
43. Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications10.1038/s41575-021-00508-3 ↗
44. Therapy resistance mediated by cancer stem cells10.1016/j.semcancer.2018.11.006 ↗
45. RBMS2 chemosensitizes breast cancer cells to doxorubicin by regulating BMF expression10.7150/ijbs.66480 ↗
46. Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer10.1038/cdd.2016.33 ↗
47. Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells10.1038/cdd.2008.190 ↗
48. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?10.1016/j.stem.2015.02.015 ↗
49. Extracellular matrix: a dynamic microenvironment for stem cell niche10.1016/j.bbagen.2014.01.010 ↗
50. Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling10.1186/s12943-021-01435-2 ↗
51. A biocompatible hydrogel with improved stiffness and hydrophilicity for modular tissue engineering assembly10.1039/C5TB00129C ↗
52. Biocompatibility evaluation of a 3D-bioprinted alginate-GelMA-bacteria nanocellulose (BNC) scaffold laden with oriented-growth RSC96 cells10.1016/j.msec.2021.112393 ↗
53. Cell-cell interaction in a coculture system consisting of CRISPR/Cas9 mediated GFP knock-in HUVECs and MG-63 cells in alginate-GelMA based nanocomposites hydrogel as a 3D scaffold10.1002/jbm.a.36928 ↗
54. Design of injectable hydrogels of gelatin and alginate with ferric ions for cell transplantation10.1016/j.actbio.2019.10.001 ↗
55. Sodium alginate: a biopolymeric catalyst for the synthesis of novel and known polysubstituted pyrano[3,2-c]chromenes10.1016/j.ijbiomac.2019.08.154 ↗
56. Alginate-gelatin-matrigel hydrogels enable the development and multigenerational passaging of patient-derived 3D bioprinted cancer spheroid models10.1088/1758-5090/abdb87 ↗
57. Cytoprotective and cytofunctional effect of polyanionic polysaccharide alginate and gelatin microspheres on rat cardiac cells10.1016/j.ijbiomac.2020.06.018 ↗
58. Microfluidic encapsulation supports stem cell viability, proliferation, and neuronal differentiation10.1089/ten.tec.2017.0368 ↗
59. Biomaterials and engineered microenvironments to control YAP/TAZ-dependent cell behaviour10.1038/s41563-018-0180-8 ↗
60. YAP/TAZ link cell mechanics to notch signalling to control epidermal stem cell fate10.1038/ncomms15206 ↗
61. Matrix stiffness regulates chemosensitivity, stemness characteristics, and autophagy in breast cancer cells10.1021/acsabm.0c00448 ↗
62. Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis10.1126/science.1062257 ↗
63. Matrix stiffness promotes glioma cell stemness by activating BCL9l/Wnt/β-catenin signaling10.18632/aging.202449 ↗
64. FOXM1 repression increases mitotic death upon antimitotic chemotherapy through BMF upregulation10.1038/s41419-021-03822-5 ↗
65. MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality10.1158/1078-0432.CCR-09-0092 ↗
66. Concise review: cheating death for a better transplant10.1002/stem.2901 ↗
67. Targeting extracellular matrix stiffness to attenuate disease: from molecular mechanisms to clinical trials10.1126/scitranslmed.aao0475 ↗
68. Fabrication and characterization of chitosan-hyaluronic acid scaffolds with varying stiffness for glioblastoma cell culture10.1002/adhm.201800295 ↗